 | • レポートコード：GIR201114173 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、糖尿病黄斑浮腫薬の世界市場を調査対象にし、糖尿病黄斑浮腫薬の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（硝子体内注射、硝子体内インプラント）、用途別分析（抗VEGF、コルチコステロイド、その他）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：Novartis、Hoffman-La Roche、Bayer、Allergan、Valeant、Alimera ・企業別売上、市場シェア ・糖尿病黄斑浮腫薬の地域別市場分析 ・糖尿病黄斑浮腫薬の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・糖尿病黄斑浮腫薬のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・糖尿病黄斑浮腫薬のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・糖尿病黄斑浮腫薬の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・糖尿病黄斑浮腫薬の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・糖尿病黄斑浮腫薬の種類別市場規模2015-2020：硝子体内注射、硝子体内インプラント ・糖尿病黄斑浮腫薬の用途別市場規模2015-2020：抗VEGF、コルチコステロイド、その他 ・糖尿病黄斑浮腫薬の世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論 |
Market Overview
The global Diabetic Macular Edema Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Diabetic Macular Edema Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Diabetic Macular Edema Drug market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Diabetic Macular Edema Drug market has been segmented into:
Intravitreal Injections
Intravitreal Implants
By Application, Diabetic Macular Edema Drug has been segmented into:
Anti-VEGF
Corticosteroids
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Diabetic Macular Edema Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Diabetic Macular Edema Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Diabetic Macular Edema Drug market.
The report offers in-depth assessment of the growth and other aspects of the Diabetic Macular Edema Drug market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Diabetic Macular Edema Drug Market Share Analysis
Diabetic Macular Edema Drug competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Diabetic Macular Edema Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Diabetic Macular Edema Drug sales, revenue and market share for each player covered in this report.
The major players covered in Diabetic Macular Edema Drug are:
Novartis
Hoffman-La Roche
Bayer
Allergan
Valeant
Alimera
Table of Contents
1 Diabetic Macular Edema Drug Market Overview
1.1 Product Overview and Scope of Diabetic Macular Edema Drug
1.2 Classification of Diabetic Macular Edema Drug by Type
1.2.1 Global Diabetic Macular Edema Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Diabetic Macular Edema Drug Revenue Market Share by Type in 2019
1.2.3 Intravitreal Injections
1.2.4 Intravitreal Implants
1.3 Global Diabetic Macular Edema Drug Market by Application
1.3.1 Overview: Global Diabetic Macular Edema Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Anti-VEGF
1.3.3 Corticosteroids
1.3.4 Others
1.4 Global Diabetic Macular Edema Drug Market by Regions
1.4.1 Global Diabetic Macular Edema Drug Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Diabetic Macular Edema Drug (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Diabetic Macular Edema Drug Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Diabetic Macular Edema Drug Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Diabetic Macular Edema Drug Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Diabetic Macular Edema Drug Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Diabetic Macular Edema Drug Status and Prospect (2015-2025)
2 Company Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Novartis SWOT Analysis
2.1.4 Novartis Product and Services
2.1.5 Novartis Diabetic Macular Edema Drug Revenue, Gross Margin and Market Share (2018-2019)
2.2 Hoffman-La Roche
2.2.1 Hoffman-La Roche Details
2.2.2 Hoffman-La Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Hoffman-La Roche SWOT Analysis
2.2.4 Hoffman-La Roche Product and Services
2.2.5 Hoffman-La Roche Diabetic Macular Edema Drug Revenue, Gross Margin and Market Share (2018-2019)
2.3 Bayer
2.3.1 Bayer Details
2.3.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Bayer SWOT Analysis
2.3.4 Bayer Product and Services
2.3.5 Bayer Diabetic Macular Edema Drug Revenue, Gross Margin and Market Share (2018-2019)
2.4 Allergan
2.4.1 Allergan Details
2.4.2 Allergan Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Allergan SWOT Analysis
2.4.4 Allergan Product and Services
2.4.5 Allergan Diabetic Macular Edema Drug Revenue, Gross Margin and Market Share (2018-2019)
2.5 Valeant
2.5.1 Valeant Details
2.5.2 Valeant Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Valeant SWOT Analysis
2.5.4 Valeant Product and Services
2.5.5 Valeant Diabetic Macular Edema Drug Revenue, Gross Margin and Market Share (2018-2019)
2.6 Alimera
2.6.1 Alimera Details
2.6.2 Alimera Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Alimera SWOT Analysis
2.6.4 Alimera Product and Services
2.6.5 Alimera Diabetic Macular Edema Drug Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Diabetic Macular Edema Drug Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Diabetic Macular Edema Drug Players Market Share
3.2.2 Top 10 Diabetic Macular Edema Drug Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Diabetic Macular Edema Drug Revenue and Market Share by Regions
4.2 North America Diabetic Macular Edema Drug Revenue and Growth Rate (2015-2020)
4.3 Europe Diabetic Macular Edema Drug Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Diabetic Macular Edema Drug Revenue and Growth Rate (2015-2020)
4.5 South America Diabetic Macular Edema Drug Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Diabetic Macular Edema Drug Revenue and Growth Rate (2015-2020)
5 North America Diabetic Macular Edema Drug Revenue by Countries
5.1 North America Diabetic Macular Edema Drug Revenue by Countries (2015-2020)
5.2 USA Diabetic Macular Edema Drug Revenue and Growth Rate (2015-2020)
5.3 Canada Diabetic Macular Edema Drug Revenue and Growth Rate (2015-2020)
5.4 Mexico Diabetic Macular Edema Drug Revenue and Growth Rate (2015-2020)
6 Europe Diabetic Macular Edema Drug Revenue by Countries
6.1 Europe Diabetic Macular Edema Drug Revenue by Countries (2015-2020)
6.2 Germany Diabetic Macular Edema Drug Revenue and Growth Rate (2015-2020)
6.3 UK Diabetic Macular Edema Drug Revenue and Growth Rate (2015-2020)
6.4 France Diabetic Macular Edema Drug Revenue and Growth Rate (2015-2020)
6.5 Russia Diabetic Macular Edema Drug Revenue and Growth Rate (2015-2020)
6.6 Italy Diabetic Macular Edema Drug Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Diabetic Macular Edema Drug Revenue by Countries
7.1 Asia-Pacific Diabetic Macular Edema Drug Revenue by Countries (2015-2020)
7.2 China Diabetic Macular Edema Drug Revenue and Growth Rate (2015-2020)
7.3 Japan Diabetic Macular Edema Drug Revenue and Growth Rate (2015-2020)
7.4 Korea Diabetic Macular Edema Drug Revenue and Growth Rate (2015-2020)
7.5 India Diabetic Macular Edema Drug Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Diabetic Macular Edema Drug Revenue and Growth Rate (2015-2020)
8 South America Diabetic Macular Edema Drug Revenue by Countries
8.1 South America Diabetic Macular Edema Drug Revenue by Countries (2015-2020)
8.2 Brazil Diabetic Macular Edema Drug Revenue and Growth Rate (2015-2020)
8.3 Argentina Diabetic Macular Edema Drug Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Diabetic Macular Edema Drug by Countries
9.1 Middle East & Africa Diabetic Macular Edema Drug Revenue by Countries (2015-2020)
9.2 Saudi Arabia Diabetic Macular Edema Drug Revenue and Growth Rate (2015-2020)
9.3 UAE Diabetic Macular Edema Drug Revenue and Growth Rate (2015-2020)
9.4 Egypt Diabetic Macular Edema Drug Revenue and Growth Rate (2015-2020)
9.5 South Africa Diabetic Macular Edema Drug Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Diabetic Macular Edema Drug Revenue and Market Share by Type (2015-2020)
10.2 Global Diabetic Macular Edema Drug Market Forecast by Type (2019-2024)
10.3 Intravitreal Injections Revenue Growth Rate (2015-2025)
10.4 Intravitreal Implants Revenue Growth Rate (2015-2025)
11 Global Diabetic Macular Edema Drug Market Segment by Application
11.1 Global Diabetic Macular Edema Drug Revenue Market Share by Application (2015-2020)
11.2 Diabetic Macular Edema Drug Market Forecast by Application (2019-2024)
11.3 Anti-VEGF Revenue Growth (2015-2020)
11.4 Corticosteroids Revenue Growth (2015-2020)
11.5 Others Revenue Growth (2015-2020)
12 Global Diabetic Macular Edema Drug Market Size Forecast (2021-2025)
12.1 Global Diabetic Macular Edema Drug Market Size Forecast (2021-2025)
12.2 Global Diabetic Macular Edema Drug Market Forecast by Regions (2021-2025)
12.3 North America Diabetic Macular Edema Drug Revenue Market Forecast (2021-2025)
12.4 Europe Diabetic Macular Edema Drug Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Diabetic Macular Edema Drug Revenue Market Forecast (2021-2025)
12.6 South America Diabetic Macular Edema Drug Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Diabetic Macular Edema Drug Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Diabetic Macular Edema Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Diabetic Macular Edema Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Diabetic Macular Edema Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Diabetic Macular Edema Drug Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Novartis Corporate Information, Location and Competitors
Table 6. Novartis Diabetic Macular Edema Drug Major Business
Table 7. Novartis Diabetic Macular Edema Drug Total Revenue (USD Million) (2017-2018)
Table 8. Novartis SWOT Analysis
Table 9. Novartis Diabetic Macular Edema Drug Product and Solutions
Table 10. Novartis Diabetic Macular Edema Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Hoffman-La Roche Corporate Information, Location and Competitors
Table 12. Hoffman-La Roche Diabetic Macular Edema Drug Major Business
Table 13. Hoffman-La Roche Diabetic Macular Edema Drug Total Revenue (USD Million) (2018-2019)
Table 14. Hoffman-La Roche SWOT Analysis
Table 15. Hoffman-La Roche Diabetic Macular Edema Drug Product and Solutions
Table 16. Hoffman-La Roche Diabetic Macular Edema Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Bayer Corporate Information, Location and Competitors
Table 18. Bayer Diabetic Macular Edema Drug Major Business
Table 19. Bayer Diabetic Macular Edema Drug Total Revenue (USD Million) (2017-2018)
Table 20. Bayer SWOT Analysis
Table 21. Bayer Diabetic Macular Edema Drug Product and Solutions
Table 22. Bayer Diabetic Macular Edema Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Allergan Corporate Information, Location and Competitors
Table 24. Allergan Diabetic Macular Edema Drug Major Business
Table 25. Allergan Diabetic Macular Edema Drug Total Revenue (USD Million) (2017-2018)
Table 26. Allergan SWOT Analysis
Table 27. Allergan Diabetic Macular Edema Drug Product and Solutions
Table 28. Allergan Diabetic Macular Edema Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Valeant Corporate Information, Location and Competitors
Table 30. Valeant Diabetic Macular Edema Drug Major Business
Table 31. Valeant Diabetic Macular Edema Drug Total Revenue (USD Million) (2017-2018)
Table 32. Valeant SWOT Analysis
Table 33. Valeant Diabetic Macular Edema Drug Product and Solutions
Table 34. Valeant Diabetic Macular Edema Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Alimera Corporate Information, Location and Competitors
Table 36. Alimera Diabetic Macular Edema Drug Major Business
Table 37. Alimera Diabetic Macular Edema Drug Total Revenue (USD Million) (2017-2018)
Table 38. Alimera SWOT Analysis
Table 39. Alimera Diabetic Macular Edema Drug Product and Solutions
Table 40. Alimera Diabetic Macular Edema Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Global Diabetic Macular Edema Drug Revenue (Million USD) by Players (2015-2020)
Table 42. Global Diabetic Macular Edema Drug Revenue Share by Players (2015-2020)
Table 43. Global Diabetic Macular Edema Drug Revenue (Million USD) by Regions (2015-2020)
Table 44. Global Diabetic Macular Edema Drug Revenue Market Share by Regions (2015-2020)
Table 45. North America Diabetic Macular Edema Drug Revenue by Countries (2015-2020)
Table 46. North America Diabetic Macular Edema Drug Revenue Market Share by Countries (2015-2020)
Table 47. Europe Diabetic Macular Edema Drug Revenue (Million USD) by Countries (2015-2020)
Table 48. Asia-Pacific Diabetic Macular Edema Drug Revenue (Million USD) by Countries (2015-2020)
Table 49. South America Diabetic Macular Edema Drug Revenue by Countries (2015-2020)
Table 50. South America Diabetic Macular Edema Drug Revenue Market Share by Countries (2015-2020)
Table 51. Middle East and Africa Diabetic Macular Edema Drug Revenue (Million USD) by Countries (2015-2020)
Table 52. Middle East and Africa Diabetic Macular Edema Drug Revenue Market Share by Countries (2015-2020)
Table 53. Global Diabetic Macular Edema Drug Revenue (Million USD) by Type (2015-2020)
Table 54. Global Diabetic Macular Edema Drug Revenue Share by Type (2015-2020)
Table 55. Global Diabetic Macular Edema Drug Revenue Forecast by Type (2021-2025)
Table 56. Global Diabetic Macular Edema Drug Revenue by Application (2015-2020)
Table 57. Global Diabetic Macular Edema Drug Revenue Share by Application (2015-2020)
Table 58. Global Diabetic Macular Edema Drug Revenue Forecast by Application (2021-2025)
Table 59. Global Diabetic Macular Edema Drug Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Diabetic Macular Edema Drug Picture
Figure 2. Global Diabetic Macular Edema Drug Revenue Market Share by Type in 2019
Figure 3. Intravitreal Injections Picture
Figure 4. Intravitreal Implants Picture
Figure 5. Diabetic Macular Edema Drug Revenue Market Share by Application in 2019
Figure 6. Anti-VEGF Picture
Figure 7. Corticosteroids Picture
Figure 8. Others Picture
Figure 9. Global Diabetic Macular Edema Drug Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America Diabetic Macular Edema Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe Diabetic Macular Edema Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific Diabetic Macular Edema Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America Diabetic Macular Edema Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa Diabetic Macular Edema Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Diabetic Macular Edema Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Diabetic Macular Edema Drug Revenue Share by Players in 2019
Figure 17. Global Top 5 Players Diabetic Macular Edema Drug Revenue Market Share in 2019
Figure 18. Global Top 10 Players Diabetic Macular Edema Drug Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global Diabetic Macular Edema Drug Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global Diabetic Macular Edema Drug Revenue Market Share by Regions (2015-2020)
Figure 22. Global Diabetic Macular Edema Drug Revenue Market Share by Regions in 2018
Figure 23. North America Diabetic Macular Edema Drug Revenue and Growth Rate (2015-2020)
Figure 24. Europe Diabetic Macular Edema Drug Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific Diabetic Macular Edema Drug Revenue and Growth Rate (2015-2020)
Figure 26. South America Diabetic Macular Edema Drug Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa Diabetic Macular Edema Drug Revenue and Growth Rate (2015-2020)
Figure 28. North America Diabetic Macular Edema Drug Revenue Market Share by Countries (2015-2020)
Figure 29. North America Diabetic Macular Edema Drug Revenue Market Share by Countries in 2019
Figure 30. USA Diabetic Macular Edema Drug Revenue and Growth Rate (2015-2020)
Figure 31. Canada Diabetic Macular Edema Drug Revenue and Growth Rate (2015-2020)
Figure 32. Mexico Diabetic Macular Edema Drug Revenue and Growth Rate (2015-2020)
Figure 33. Europe Diabetic Macular Edema Drug Revenue Market Share by Countries (2015-2020)
Figure 34. Europe Diabetic Macular Edema Drug Revenue Market Share by Countries in 2019
Figure 35. Germany Diabetic Macular Edema Drug Revenue and Growth Rate (2015-2020)
Figure 36. UK Diabetic Macular Edema Drug Revenue and Growth Rate (2015-2020)
Figure 37. France Diabetic Macular Edema Drug Revenue and Growth Rate (2015-2020)
Figure 38. Russia Diabetic Macular Edema Drug Revenue and Growth Rate (2015-2020)
Figure 39. Italy Diabetic Macular Edema Drug Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Diabetic Macular Edema Drug Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific Diabetic Macular Edema Drug Revenue Market Share by Countries in 2019
Figure 42. China Diabetic Macular Edema Drug Revenue and Growth Rate (2015-2020)
Figure 43. Japan Diabetic Macular Edema Drug Revenue and Growth Rate (2015-2020)
Figure 44. Korea Diabetic Macular Edema Drug Revenue and Growth Rate (2015-2020)
Figure 45. India Diabetic Macular Edema Drug Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia Diabetic Macular Edema Drug Revenue and Growth Rate (2015-2020)
Figure 47. South America Diabetic Macular Edema Drug Revenue Market Share by Countries (2015-2020)
Figure 48. South America Diabetic Macular Edema Drug Revenue Market Share by Countries in 2019
Figure 49. Brazil Diabetic Macular Edema Drug Revenue and Growth Rate (2015-2020)
Figure 50. Argentina Diabetic Macular Edema Drug Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa Diabetic Macular Edema Drug Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa Diabetic Macular Edema Drug Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia Diabetic Macular Edema Drug Revenue and Growth Rate (2015-2020)
Figure 54. UAE Diabetic Macular Edema Drug Revenue and Growth Rate (2015-2020)
Figure 55. Egypt Diabetic Macular Edema Drug Revenue and Growth Rate (2015-2020)
Figure 56. South Africa Diabetic Macular Edema Drug Revenue and Growth Rate (2015-2020)
Figure 57. Global Diabetic Macular Edema Drug Revenue Share by Type (2015-2020)
Figure 58. Global Diabetic Macular Edema Drug Revenue Share by Type in 2019
Figure 59. Global Diabetic Macular Edema Drug Market Share Forecast by Type (2021-2025)
Figure 60. Global Intravitreal Injections Revenue Growth Rate (2015-2020)
Figure 61. Global Intravitreal Implants Revenue Growth Rate (2015-2020)
Figure 62. Global Diabetic Macular Edema Drug Revenue Share by Application (2015-2020)
Figure 63. Global Diabetic Macular Edema Drug Revenue Share by Application in 2019
Figure 64. Global Diabetic Macular Edema Drug Market Share Forecast by Application (2021-2025)
Figure 65. Global Anti-VEGF Revenue Growth Rate (2015-2020)
Figure 66. Global Corticosteroids Revenue Growth Rate (2015-2020)
Figure 67. Global Others Revenue Growth Rate (2015-2020)
Figure 68. Global Diabetic Macular Edema Drug Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global Diabetic Macular Edema Drug Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global Diabetic Macular Edema Drug Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America Diabetic Macular Edema Drug Revenue Market Forecast (2021-2025)
Figure 72. Europe Diabetic Macular Edema Drug Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific Diabetic Macular Edema Drug Revenue Market Forecast (2021-2025)
Figure 74. South America Diabetic Macular Edema Drug Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa Diabetic Macular Edema Drug Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
黄斑変性症（AMD）及びその他の網膜疾患の世界市場 2020年 Market Overview The global Macular Degeneration (AMD) and Other Retinal Diseases market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2…- 加齢黄斑変性症治療薬の世界市場 2020年 Market Overview The Age Related Macular Degeneration Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value cha…
- ラニビズマブの世界市場 2020年 Market Overview The global Ranibizumab market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Ranibizumab market report provide…
- 若年性黄斑変性症治療の世界市場 2020年 Market Overview The global Juvenile Macular Degeneration Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Juven…
- 糖尿病性ケトアシドーシス治療の世界市場 2020年 Market Overview The global Diabetic Ketoacidosis Treatments market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Diabetic Ket…